EP2305245
Meðferð við sjúkdómum er tengjast notkun fúkkalyfja
Status:
EP Einkaleyfi útrunniðEP appl. date:
13.5.2005EP published:
2.1.2019EP application number:
10075450.6
EP translation filed:
27.2.2019Grant published:
15.3.2019EPO information:
European Patent Register
Max expiry date:
12.5.2025Expiry date:
12.5.2025
Title:
Treatment of diseases associated with the use of antibiotics
Timeline
Today
13.5.2005EP application
2.1.2019EP Publication
27.2.2019Translation submitted
15.3.2019Registration published
12.5.2025Expires
Owner
Name:
Merck Sharp & Dohme LLCAddress:
126 East Lincoln Avenue, Rahway, New Jersey 07065, US
Inventor
Name:
Shue, Youe-KongAddress:
CarlsbadCalifornia, US
Name:
Babakhani, Farah KondoriAddress:
San DiegoCalifornia, US
Name:
Okumu, Franklin W.Address:
OaklandCalifornia, US
Name:
Sears, Pamela SuzanneAddress:
San DiegoCalifornia, US
Name:
Miller-Shangle, Starr LouiseAddress:
San DiegoCalifornia, US
Name:
Walsh, Robert BrianAddress:
DavisCalifornia, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
570697 PDate:
14.5.2004Country:
US
Classification
Categories:
A61K 31/335, A61K 31/7048, A61K 31/365, A61P 1/12, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 15
Paid: 1.3.2019
Expires: 12.5.2020
Payer: G. H. Sigurgeirsson
Number: 16
Paid: 14.4.2020
Expires: 12.5.2021
Payer: Örn Þór slf.
Number: 17
Paid: 12.4.2021
Expires: 12.5.2022
Payer: Örn Þór slf.
Number: 18
Paid: 22.4.2022
Expires: 12.5.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 12.4.2023
Expires: 12.5.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 12.4.2024
Expires: 12.5.2025
Payer: Árnason Faktor ehf.